HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paraneoplastic Syndromes (Paraneoplastic Syndrome)

In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
Also Known As:
Paraneoplastic Syndrome; Syndrome, Paraneoplastic; Syndromes, Paraneoplastic
Networked: 1065 relevant articles (35 outcomes, 24 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
3. Lung Neoplasms (Lung Cancer)
4. Oncogenic osteomalacia
5. Hypercalcemia (Milk Alkali Syndrome)

Experts

1. Takahashi, Yutaka: 6 articles (01/2022 - 10/2018)
2. Fukumoto, Seiji: 5 articles (01/2022 - 07/2003)
3. Dalmau, Josep: 5 articles (09/2012 - 02/2004)
4. Dalmau, J: 5 articles (09/2008 - 03/2000)
5. Bando, Hironori: 4 articles (01/2022 - 10/2018)
6. Kanie, Keitaro: 4 articles (01/2022 - 10/2018)
7. Xia, Weibo: 4 articles (01/2022 - 12/2018)
8. Collins, Michael T: 4 articles (01/2021 - 11/2013)
9. Sarnatskaya, V V: 4 articles (01/2019 - 06/2013)
10. Yushko, L A: 4 articles (01/2019 - 06/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Paraneoplastic Syndromes:
1. AntibodiesIBA
2. Intravenous Immunoglobulins (IVIG)FDA Link
3. Parathyroid Hormone-Related ProteinIBA
4. Rituximab (Mabthera)FDA Link
5. Proteins (Proteins, Gene)FDA Link
6. Fibroblast Growth Factor-23IBA
7. Adrenal Cortex Hormones (Corticosteroids)IBA
8. SteroidsIBA
9. Semaphorin-3AIBA
04/01/2020 - "Autoimmunity against collapsin response-mediator protein-5 (anti-CRMP-5) has been associated with ocular inflammation in paraneoplastic syndrome. "
01/01/2021 - "Targeted and immune checkpoint therapies have improved survival for patients with melanoma and lung cancer and have simultaneously produced novel complications by enhancing radiation toxicity in some cases and by facilitating the emergence of novel autoimmune and paraneoplastic syndromes involving the spinal cord, such as neuromyelitis optica spectrum disorder and syndromes associated with anti-Hu and collapsin response mediator protein-5 (CRMP-5) antibodies. "
01/01/2022 - "We highlight up to date information regarding this heterogeneous group of disorders, including a discussion of parainfectious Sydenham's chorea; paraneoplastic syndromes associated with CRMP-5 (collapsin response mediated protein-5/CV2) and ANNA-1 (antineuronal nuclear antibody / Hu) antibodies, in addition to neuronal antibody-associated disorders including anti-NMDAR, LGI1 (leucine-rich glioma inactivated-1) and CASPR2 (contactin associated protein-2). "
02/01/2009 - "Collapsin response mediator protein 5 (CRMP5) antibodies are often associated with thymoma or small cell lung cancer and paraneoplastic syndromes such as limbic encephalitis (LE). "
12/01/2022 - "We may also predict the response to treatment based on the autoantibody class. We are presenting a very unusual case of two completely different paraneoplastic syndromes with two different autoantibodies, gamma-aminobutyric acid-B (GABAB) and collapsin response mediator protein 5 (CRMP5), in a patient with underlying small-cell lung cancer. "
10. Octreotide (Sandostatin)FDA LinkGeneric

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Therapeutics
3. Immunotherapy
4. Chemoradiotherapy
5. Plasmapheresis